RxDoctor Payments Data

Tanner Thornton, PA

Physician Assistant · Chandler, AZNPI 1972121036

Payments from drug & device makers

$8,906in general payments, 2019–2025

Across 608 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$2K
  • Biohaven Pharmaceuticals, Inc.$986
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$928
  • Boston Scientific$686
  • Vertos Medical, Inc.$458
  • Scilex Pharmaceuticals Inc.$408
  • plus $4K from 38 others

What the payments were for

  • Consulting fees$8009%
  • Food & beverage$7,97990%
  • Education$1281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,906 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$107,932
Medicare patients
271
Services billed
2,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate95$62,143
RelistorMethylnaltrexone Bromide23$53,565
MovantikNaloxegol Oxalate76$35,488
BelbucaBuprenorphine Hcl40$31,179
UbrelvyUbrogepant24$24,108
OxycontinOxycodone Hcl47$21,443
Nurtec OdtRimegepant Sulfate18$19,366
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen578$19,218
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen494$17,032
Buprenorphine69$16,609
Nucynta ErTapentadol Hcl13$13,605
ButransBuprenorphine22$10,555
Tramadol Hcl ErTramadol Hcl95$7,999
Oxycodone Hcl402$7,236
Gabapentin458$7,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er$1,674$106,927148 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$928$53,56523 claims
Redhill Biopharma Inc.Movantik$29$35,48876 claims
AbbVieUbrelvy$359$24,10824 claims
PfizerNurtec Odt$266$19,36618 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$172$18,182153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →